Protective effects of the sigma agonist Pre-084 in the rat retina

British Journal of Ophthalmology

Volumn 91, Issue 10, 2007, Pages 1382-1384

  Cantarella, Giuseppina ^a   Bucolo, Claudio ^a   Di Benedetto, Giulia ^a   Pezzino, Salvatore ^a   Lempereur, Laurence ^a   Calvagna, Rosa ^a   Clementi, Silvia ^a   Pavone, Piero ^a   Fiore, Lucia ^a   Bernardini, Renato ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHENYLCYCLOHEXANECARBOXYLIC ACID 2 MORPHOLINOETHYL ESTER; AMYLOID BETA PROTEIN; DEATH RECEPTOR 4; N [2 (2,3 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; OPIATE ANTAGONIST; PROTEIN BAX; SIGMA 1 OPIATE RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RETINA INJURY;

AMYLOID BETA-PROTEIN; ANIMALS; BCL-2-ASSOCIATED X PROTEIN; ETHYLENEDIAMINES; INJECTIONS; MALE; MAP KINASE KINASE 4; MODELS, ANIMAL; MORPHOLINES; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RETINA; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; VITREOUS BODY;

EID: 34848903917     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.118570     Document Type: Article

References (22)

1. Selkoe DJ. Alzheimer's disease: a central role for amyloid. J Neuropathol Expl Neurol 1994;53:438-47.
2. Jen LS, Hart AJ, Jen A, et al. Alzheimer's peptide kills cells of retina in vivo. Nature 1998;392:140-1.
3. Cantarella G, Uberti D, Carsana T, et al. Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity. Cell Death Diff 2003;10:134-41.
4. Lee HO, Herndon JM, Barreiro R, et al. TRAIL: a mechanism of tumor surveillance in an immune privileged site. J Immunol 2002;169:4739-44.
5. Gupta S, Barrett T, Whitmarsh AJ, et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996;15:2760-70.
6. Le Blanc H, Lawrence D, Varfolomeev E, et al. Tumour-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med 2002;8:274-81.
7. Sandra F, Hendarmin L, Nakamura S. Osteoprotegerin (OPG) binds with tumour necrosis factor-related apoptosis-inducing ligand (TRAIL): suppression of TRAIL-induced apoptosis in ameloblastomas. Oral Oncol 2006;42:415-20.
8. Quirion R, Bowen WD, Itzhak Y, et al. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 1992;13:85-6.
9. Roy S, Loh H. Effects of opioids on the immune system. Neurochem Res 1996;21:1375-86.
10. Bucolo C, Campana G, Di Tora R, et al. Sigma1 recognition sites in rabbit irisciliary body: topical sigma1-site agonists lower intraocular pressure. J Pharmacol Exp Ther 1999;289:1362-9.
11. Senda T, Matsuno K, Mita S. The presence of sigma receptor subtypes in bovine retinal membranes. Exp Eye Res 1997;64:857-60.
12. Marrazzo A, Caraci F, Salinaro ET, et al. Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity. Neuroreport 2005;16:1223-6.
13. Martin PM, Ola MS, Agarwal N, et al. The sigma receptor ligand (+)-pentazocine prevents apoptotic retinal ganglion cell death induced in vitro by homocysteine and glutamate. Brain Res Mol Brain Res 2004;123:66-75.
14. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. NY: Cold Spring Harbor Laboratory Press, 1989;3:18.47-18.75.
15. Yoshida T, Ohno-Matsui K, Ichinose S, et al. The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest 2005;115:2793-800.
16. Minogue AM, Schmid AW, Fogarty MP, et al. Activation of the c-Jun N-terminal kinase signalling cascade mediates the effect of amyloid-beta on long term potentiation and cell death in hippocampus: a role for interleukin-1 beta? J Biol Chem 2003;278:27971-8.
17. Johnson LV, Leinter WP, Rivest AJ, et al. The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA 2002;99:11830-5.
18. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophtalmol Vis Sci 2002;43:1077-87.
19. Moreno MC, Campanelli J, Sande P, et al. Retinal oxidative stress induced by high intraocular pressure. Free Radic Biol Med 2004;37:803-12.
20. Louzada PR, Lima AC, Mendonca-Silva DL, et al. Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders. FASEB J 2004;18:511-8.
21. Bucolo C, Drago F, Lin LR, et al. Sigma receptor ligands protect human retinal cells against oxidative stress. Neuroreport 2006;17:287-91.
22. Spruce BA, Campbell LA, McTavish N, et al. Small molecule antagonists of the σ-1 receptor cause selective release of the death program in tumour and self-reliant cells and inhibit tumour growth in vitro and in vivo. Cancer Res 2004;64:4875-86.